MASSACHUSETTS GENERAL HOSPITAL

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1811-01-01

Employees: -

Market Cap: -

Website: http://www.massgeneral.org/international

Clinical Trials

Intensity-Modulated or Proton Radiation Therapy for Sinonasal Malignancy

Not Applicable

Active, not recruiting

Conditions: Sinonasal Undifferentiated Carcinoma
Adenoid Cystic Carcinoma
Squamous Cell Carcinoma
Melanoma
Sinonasal Carcinoma
Schneiderian Carcinoma
Esthesioneuroblastoma
Myoepithelial Carcinoma
Mucoepidermoid Carcinoma

Interventions: Radiation: Intensity-modulated radiotherapy
Radiation: Proton radiation therapy

First Posted Date: 2012-04-27

Last Posted Date: 2023-09-21

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 45

Registration Number: NCT01586767

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States

Intervention to Increase Chemotherapy Tolerance in Elderly Cancer Patients

Not Applicable

Conditions: Colonic Neoplasms

Interventions: Behavioral: Behavioral Intervention

First Posted Date: 2012-04-26

Last Posted Date: 2020-09-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 15

Registration Number: NCT01586416

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Rituximab in IgG4-RD: A Phase 1-2 Trial

Phase 1

Completed

Conditions: Retroperitoneal Fibrosis
Autoimmune Pancreatitis
Sialadenitis
Pseudotumor

Interventions: Drug: Rituximab

First Posted Date: 2012-04-25

Last Posted Date: 2017-07-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 30

Registration Number: NCT01584388

Olaparib in Adults With Recurrent/Metastatic Ewing's Sarcoma

Phase 2

Completed

Conditions: Ewing's Sarcoma

Interventions: Drug: Olaparib

First Posted Date: 2012-04-24

Last Posted Date: 2017-05-19

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 12

Registration Number: NCT01583543

Locations: 🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States

Complex Dynamic Systems in Mood Disorders

Completed

Conditions: Bipolar Disorder
Major Depressive Disorder

First Posted Date: 2012-04-24

Last Posted Date: 2015-10-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 20

Registration Number: NCT01583569

Locations: 🇺🇸
Bipolar Clinic and Research Program at Massachusetts General Hospital, Boston, Massachusetts, United States

Optional Follow-up Visits for Common, Low-risk Arm Fractures

Completed

Conditions: Metacarpal Fracture
Metacarpal Neck Fracture
Radial Head Fracture
Mallet Fracture
Distal Radius Fracture

First Posted Date: 2012-04-24

Last Posted Date: 2015-04-07

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 120

Registration Number: NCT01583556

Locations: 🇺🇸
Hand Service, Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, United States

Ketamine Infusion for Treatment-resistant Major Depressive Disorder

Not Applicable

Completed

Conditions: Major Depressive Disorder

Interventions: Drug: Ketamine

First Posted Date: 2012-04-23

Last Posted Date: 2017-04-20

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 14

Registration Number: NCT01582945

Locations: 🇺🇸
Depression Clinical and Research Program - MGH, Boston, Massachusetts, United States

External-Beam Partial-Breast Irradiation for Early Breast Cancer 40 Gy QD Over 2 Weeks

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Radiation: External Beam Partial-Breast Irradiation

First Posted Date: 2012-04-20

Last Posted Date: 2020-11-02

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 54

Registration Number: NCT01581619

Locations: 🇺🇸
Beth Isreal Deaconness Medical Center, Boston, Massachusetts, United States
🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Brigham and Women's Hosptial, Boston, Massachusetts, United States

and more 1 locations

XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease

Phase 1

Completed

Conditions: Multiple Myeloma

Interventions: Drug: Cabozantinib

First Posted Date: 2012-04-20

Last Posted Date: 2017-05-25

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 4

Registration Number: NCT01582295

Locations: 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Massachusetts General Hospital, Boston, Massachusetts, United States

Potential Use Of Brain Network Activation Analysis to Diagnose Major Depression

Terminated

Conditions: Major Depressive Disorder

First Posted Date: 2012-04-18

Last Posted Date: 2017-03-06

Lead Sponsor: Massachusetts General Hospital

Target Recruit Count: 70

Registration Number: NCT01579942

Locations: 🇺🇸
Depression Clinical and Research Program, Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy